Computed tomography (CT) is an essential tool in oncologic imaging, particularly for assessing thoracoabdominal structures in the portal venous phase. However, the widespread use of iodinated contrast medium (CM) in CT scans raises concerns regarding patient safety, environmental consequences and healthcare expenses. Excessive iodine exposure can lead to adverse effects, particularly in vulnerable patient populations, and managing CM usage efficiently is of significant interest in medical imaging. Photon-counting detector CT (PCD-CT) technology has emerged as an innovative solution with the potential to reduce CM administration while preserving high-quality imaging. A recent study published in European Radiology evaluates the feasibility of CM volume reduction in portal venous phase PCD-CT and its impact on diagnostic accuracy.
Optimising Image Quality with Reduced Contrast Medium
Reducing CM volume in CT scans requires maintaining image quality for clinical decision-making. The study conducted intra-individual comparisons between PCD-CT scans using 120 mL and 100 mL CM volumes. The results demonstrated that reducing CM volume did not lead to a statistically significant deterioration in image quality or contrast-to-noise ratio (CNR). Notably, PCD-CT scans using 100 mL CM were found to be non-inferior to both the 120 mL PCD-CT scans and conventional energy-integrating detector CT (EID-CT) scans with 120 mL CM in terms of CNR across various abdominal organs.
Additionally, virtual monoenergetic imaging (VMI) reconstructions were applied to optimise contrast enhancement at different keV levels. Standard reconstructions at 70 keV provided sufficient image quality, while additional VMI at 60 keV further increased CNR in key anatomical structures. However, subjective assessments indicated a tendency towards slight over-enhancement at lower keV levels, suggesting that reconstruction parameters must be carefully adjusted to balance image clarity and diagnostic accuracy. The findings reinforce the importance of using advanced image processing techniques to compensate for CM reduction while maintaining optimal visualisation of relevant pathology.
Comparing PCD-CT and EID-CT Performance
PCD-CT demonstrated superior image quality metrics compared to EID-CT, with higher signal-to-noise and contrast-to-noise ratios across multiple organ systems. Additionally, PCD-CT scans achieved a reduction in radiation dose while maintaining superior image clarity compared to traditional EID-CT systems. This improvement can be attributed to the photon-counting detector’s ability to fully capture low-energy x-ray quanta while minimising electronic noise, resulting in enhanced iodine contrast efficiency.
Recommended Read: Evaluating the Long-Term Stability of Photon-Counting CT Technology
Beyond the technical advantages, the improved contrast resolution in PCD-CT enhances the detection of subtle lesions, which is particularly beneficial in oncologic imaging. The ability to visualise finer anatomical details with greater clarity can improve diagnostic confidence, aiding in more accurate disease staging and treatment planning. Additionally, the reduction in CM volume in PCD-CT scans mitigates the risk of contrast-induced nephropathy, making it a safer alternative for patients with pre-existing renal impairment. This shift in imaging technology could lead to significant improvements in patient management by reducing adverse effects while ensuring high diagnostic performance.
Clinical Implications and Future Considerations
The ability to reduce CM volume without sacrificing diagnostic accuracy has important clinical implications. For patients with compromised renal function or those at risk of contrast-induced nephropathy, lower iodine doses may help mitigate adverse effects. Furthermore, given the financial and environmental impact of iodine-based contrast agents, widespread adoption of CM-reducing protocols could contribute to cost savings and a reduction in medical waste. Healthcare systems stand to benefit from optimising CM use, as reducing contrast volume without impacting diagnostic outcomes can lead to more efficient resource allocation.
Additionally, balancing CM reduction with the use of VMI ensures that diagnostic confidence is not compromised. While 60 keV VMI enhances iodine contrast, careful parameter adjustments are necessary to prevent excessive enhancement. Future research may refine existing protocols to achieve an optimal balance between contrast enhancement and iodine dose minimisation, ensuring continued improvements in diagnostic accuracy and patient outcomes.
The findings indicate that PCD-CT enables a significant reduction in CM volume while maintaining diagnostic efficacy. Through the application of advanced image processing techniques such as VMI, PCD-CT achieves high image quality that surpasses conventional EID-CT systems. This reduction in CM usage carries important implications for patient safety, healthcare costs and environmental sustainability, positioning PCD-CT as a valuable advancement in medical imaging. Further research may refine existing protocols to optimise contrast enhancement while ensuring continued improvements in diagnostic accuracy and patient care.
Source: European Radiology
Image Credit: Vecteezy
